Anti-c-myc RNAi-Based Onconanotherapeutics

Overexpression of the c-myc proto-oncogene features prominently in most human cancers. Early studies established that inhibiting the expression of oncogenic c-myc, produced potent anti-cancer effects. This gave rise to the notion that an appropriate c-myc silencing agent might provide a broadly appl...

Descripción completa

Detalles Bibliográficos
Autores principales: Habib, Saffiya, Ariatti, Mario, Singh, Moganavelli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7765184/
https://www.ncbi.nlm.nih.gov/pubmed/33333729
http://dx.doi.org/10.3390/biomedicines8120612

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7765184/
https://www.ncbi.nlm.nih.gov/pubmed/33333729
http://dx.doi.org/10.3390/biomedicines8120612

Ejemplares similares